List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 94 studies with search of: "Acetylcysteine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Treatment of Systemic Lupus Erythematosus (SLE) With N-Acetylcysteine
Condition: Systemic Lupus Erythematosus
Interventions: Other: Sugar Pill;   Drug: N-acetylcysteine;   Drug: N-acetylcysteine;   Drug: N-acetylcysteine;   Drug: N-acetylcysteine;   Drug: N-acetylcysteine
2 Recruiting A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
Conditions: Autistic Disorder;   Asperger Syndrome;   Child Development Disorders, Pervasive
Interventions: Drug: N-acetylcysteine;   Drug: Placebo
3 Recruiting N-Acetylcysteine and NMDA Antagonist Interactions
Condition: Cognitive Dysfunction
Interventions: Drug: N-acetylcysteine and ketamine;   Drug: N-acetylcysteine and ketamine
4 Recruiting Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material
Condition: Radiocontrast-Induced Nephropathy
Interventions: Drug: Acetylcysteine;   Drug: Visipaque 320;   Drug: Visipaque 320
5 Recruiting N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure
Conditions: Heart Failure, Congestive;   Kidney Failure, Chronic
Intervention: Drug: N-acetylcysteine
6 Recruiting Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1
Condition: Cocaine Dependence
Interventions: Drug: N-Acetylcysteine;   Drug: N-Acetylcysteine;   Drug: Matching Placebo
7 Not yet recruiting N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell Lung;   Mesothelioma
Interventions: Drug: N-Acetylcysteine;   Drug: Placebo
8 Completed N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography
Conditions: Contrast Induced Nephropathy;   Critically Ill
Interventions: Drug: N-acetylcysteine;   Drug: D5W Placebo
9 Recruiting Safety of N-Acetylcysteine in Maternal Chorioamnionitis (NAC in Chorio)
Conditions: Chorioamnionitis;   Brain Injury
Interventions: Drug: N-acetylcysteine;   Drug: Saline
10 Not yet recruiting The Acetylcysteine for Contrast-Induced Nephropathy Trial
Condition: Acute Kidney Failure
Interventions: Drug: Acetylcysteine;   Drug: Placebo
11 Suspended Mucomyst for Hepatitis C
Condition: Hepatitis C
Intervention: Drug: N-acetylcysteine(Mucomyst)
12 Completed Use of Mucomyst to Ameliorate Oxidant Stress in Diabetics With Proteinuria
Conditions: Diabetes;   Proteinuria
Intervention: Drug: N-acetylcysteine(Mucomyst)
13 Recruiting Influence of N-Acetylcysteine on Morbidity, Oxygenation and Cytokine Levels in Partial or Total Esophagectomy for Cancer
Condition: Pulmonary Morbidity
Interventions: Drug: n-acetylcysteine;   Drug: 250mL glucose 5%
14 Completed Optimalization of Nephroprotection Using N-Acetylcysteine
Conditions: Chronic Kidney Disease;   Proteinuria
Intervention: Drug: ACC (N-acetylcysteine) 1200 mg
15 Completed N-Acetylcysteine in Neonatal Congenital Heart Surgery (INACT Study)
Conditions: Transposition of Great Vessels;   Congenital Heart Disease
Intervention: Drug: N-acetylcysteine
16 Recruiting N-Acetylcysteine in Alcohol Dependence
Condition: Alcoholism
Interventions: Drug: N-acetylcysteine;   Drug: Placebo
17 Completed N-Acetylcysteine and Smoking Reduction
Condition: Nicotine Dependence
Interventions: Drug: N-acetylcysteine;   Drug: Placebo
18 Completed Effect of N-Acetylcysteine (NAC) on Creatinine in Chronic Kidney Disease
Condition: Chronic Kidney Disease
Interventions: Drug: N-acetylcysteine;   Drug: Placebo
19 Enrolling by invitation Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm
Conditions: Aneurysmal Subarachnoid Hemorrhage;   Cerebral Vasospasm
Interventions: Drug: Placebos for acetaminophen and N-acetylcysteine;   Drug: APAP 1 gm every 6 hours and N-acetylcysteine placebo;   Drug: NAC IV infusion at 0.5 gm hourly and APAP placebo;   Drug: APAP 1 gm q6 hours, plus NAC IV infusion at 0.5 gm hourly;   Drug: APAP 1.5 gm q6 hours, plus NAC IV infusion at 0.5 gm hourly
20 Suspended Insulin Resistance Study
Conditions: Insulin Resistance;   Metabolic Syndrome X
Interventions: Drug: N-acetylcysteine 20% 4ml;   Drug: N-acetylcysteine 20% in 4 ml

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services